Next step is moving people between both nations, says envoy after UK accepts Covishield

Credit: IndiaTimes- Published on October 9, 2021
UK high commissioner to India, Alex Ellis on Saturday said the next step post the India-UK cooperation on Covishield is to increase the flow of people between the two nations as they are desperate to come here. "We are delighted with UK-India cooperation on Covishield, those travelling from India can now enter the UK without...

Video credit: Wibbitz Top Stories
Published on October 6, 2021 -  01:30
WHO Approves First-Ever Malaria Vaccine
WHO Approves, First-Ever, Malaria Vaccine. The World Health Organization (WHO) has endorsed a vaccine shown to help prevent one of the oldest-known and deadliest infectious diseases, malaria. According to 'The New York Times,' every year, malaria reportedly kills about half a million people, mostly in sub-Saharan Africa. That number includes, 260,000 children under the age of five. The new vaccine, made by GlaxoSmithKline, targets Plasmodium falciparum, the deadliest of five malaria pathogens, which is most prevalent in Africa. The new vaccine, made by GlaxoSmithKline, targets Plasmodium falciparum, the deadliest of five malaria pathogens, which is most prevalent in Africa. On October 6, the WHO called the vaccine the first step in a process that should lead to broad distribution in poor nations. On October 6, the WHO called the vaccine the first step in a process that should lead to broad distribution in poor nations. Dr. Pedro Alonso, director of the WHO’s global malaria program, called the development of a malaria vaccine , “a historic event.”. Dr. Pedro Alonso, director of the WHO’s global malaria program, called the development of a malaria vaccine , “a historic event.”. The 'NYT' reports that the vaccine, called Mosquirix, is the first inoculation developed for any parasitic disease. The 'NYT' reports that the vaccine, called Mosquirix, is the first inoculation developed for any parasitic disease. It’s a huge jump from the science perspective to have a first-generation vaccine against a human parasite, Dr. Pedro Alonso, director of the WHO’s global malaria program, via 'The New York Times'. Last year, a modeling study estimated the vaccine could prevent 5.4 million cases and 23,000 deaths in children under the age of five each year. The malaria parasite, carried by mosquitoes, can strike the same individual multiple times. . The 'NYT' points out that in many parts of sub-Saharan Africa, children contract malaria six times a year on average

You are here


💡 newsR Knowledge: Other News Mentions

Oxford–AstraZeneca COVID-19 vaccine

Viral vector vaccine for prevention of COVID-19 by Oxford University and AstraZeneca
With not enough orders for Covishield from the Centre, Serum Institute of India CEO Adar Poonawalla on Tuesday said the company is looking at slashing monthly..
Credit: IndiaTimes - Published 15 hours ago

Up to six different Covid-19 boosters were found to be safe, and provoked strong immune responses in people who have previously received a two-dose course of the..
Credit: IndiaTimes - Published 6 days ago

Recently, Kerala, Rajasthan, Karnataka, and Chhattisgarh have also urged the Centre to decide on allowing booster doses of the COVID-19 vaccine.
Credit: DNA - Published 6 days ago



Related videos from verified sources

Roku’s ‘Streaming Decade’: Data Brains & The Richest Ad Canvas 08:07
Credit: BeetTV - Affiliate - Published 1 week ago 


You might like